Zydus Cadila
-
Zydus Cadila gets USFDA nod for generic drug
India | Dec 22, 2021, 02:31 PM ISTThe company has received tentative approval from the US Food and Drug Administration to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement.
-
Bihar, UP among seven states to be administered Zydus Cadila's ZyCoV-D vaccine first
India | Dec 02, 2021, 03:54 PM ISTZyCov-D, which is the first COVID-19 vaccine to be cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults in the seven states as of now, sources said.
-
Zydus Cadila gets FDA's approval to market generic cancer drug in US
World | Nov 20, 2021, 03:54 PM ISTThe company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.
-
Zydus Cadila's Covid vaccine to be administered only to adults as of now: Sources
India | Nov 14, 2021, 06:33 PM ISTThe health ministry has given a go ahead to initiate the preparatory work for the inclusion of the indigenously-developed, needle-free jab in the national Covid inoculation drive and it can be introduced in the programme anytime soon.
-
Zydus Cadila to reduce its 'needle-free' Covid vaccine price to Rs 265/dose: Sources
India | Oct 31, 2021, 03:01 PM ISTThe Ahmedabad-based pharma company earlier had proposed a price of Rs 1,900 for its three-dose regimen, a source had said.
-
Discussions on Zydus Cadila Covid vaccine pricing in last stage: Health Minister Mandaviya
India | Oct 26, 2021, 09:04 PM ISTThe RNA-based vaccine, meant for the age group of 12 to 18 besides adults, got the Emergency Use Authorisation from the drug regulator on August 20.
-
Just matter of time: Govt on introducing Zydus Cadila's 3-dose needle free vaccine
India | Oct 07, 2021, 06:17 PM ISTPharma company Zydus Cadila is learnt to have proposed a price of Rs 1,900 for its three-dose jab ZyCov-D that can be given to those above 12 years of age.
-
Zydus Cadila proposes price for 3-dose Covid vaccine ZyCov-D. Details
India | Oct 03, 2021, 06:25 PM ISTThe government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila will be introduced in the nationwide anti-coronavirus vaccination drive shortly.
-
What govt said on the pricing of Zydus Cadila's 3-dose upcoming vaccine
India | Oct 01, 2021, 11:47 AM IST"The call of the hour is to give the two-dose vaccination/full vaccination covering the entire adult population. The talk of booster dose is not pertinent at the moment," said ICMR DG Dr. Balram Bhargava.
-
Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources
India | Sep 11, 2021, 11:53 PM ISTZydus Cadila's coronavirus vaccine ZyCoV-D is likely to be launched in early October, according to sources.
-
Zydus Cadila gets USFDA nod for diabetes medication
Business | Sep 06, 2021, 01:24 PM ISTThe NDA received tentative approval upon completion of the first review cycle on September 2, 2021, Zydus Cadila stated.
-
Hope to start supply of ZyCoV-D vaccine by mid to end Sept: Zydus Group MD
India | Aug 21, 2021, 07:13 PM ISTThe company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.
-
'ZyCoV-D' vaccine 66% efficient against Covid Delta variant: Zydus Group MD
India | Aug 23, 2021, 03:10 PM ISTZydus Group MD Dr. Sharvil Patel has claimed that 'ZyCoV-D' vaccine holds about 66% efficacy against the Delta variant of COVID-19.
-
Zydus Cadila's ZyCoV-D Covid vaccine gets approval for emergency use in India
News | Aug 21, 2021, 08:20 AM ISTThe Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.
-
Zydus Cadila's 'ZyCoV-D' vaccine approved for emergency use: Can your child get it?
India | Aug 23, 2021, 01:21 PM ISTZyCoV-D vaccine: Zydus Cadila's 3-dose vaccine 'ZyCoV-D' has finally got approval for emergency use by India's central drug authority. The vaccine is the world's first and India's indigenously developed DNA-based vaccine for Covid-19.
-
Zydus Cadila's Covid vaccine ZyCoV-D gets approval for Emergency Use Authorisation
News | Aug 20, 2021, 09:05 PM ISTThe Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.
-
Zydus Cadila's ZyCoV-D vaccine approved for emergency use; can be used on children too
India | Aug 20, 2021, 09:12 PM ISTThe Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said.
-
Govt panel recommends emergency use authorisation to Zydus Cadila's Covid vaccine
India | Aug 20, 2021, 05:52 PM ISTAn expert panel of India's central drug authority has recommended granting emergency use authorisation to Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D, sources said.
-
Zydus Cadila's Covid vaccine to get Govt's approval this week: Report
India | Aug 09, 2021, 12:37 PM ISTZydus Cadila's needle-free COVID-19 vaccine 'ZyCoV-D' will be the sixth Covid vaccine to be available in India.
-
Zydus Cadila seeks DGCI nod for its Covid-19 vaccine ZyCoV-D
India | Jul 01, 2021, 11:25 AM ISTZydus Cadila seeks Emergency Use Authorisation for its DNA vaccine, ZyCoV-D, for 12 years and above in India.